PiperJaffray Initiates Coverage on Sanofi SA (ADR) to Neutral

PiperJaffray Initiates Coverage on Sanofi SA (ADR)(NYSE:SNY). The shares have been rated Neutral. The rating by PiperJaffray was issued on Sep 23, 2016.

Sanofi SA (ADR) (SNY) made into the market gainers list on Tuesdays trading session with the shares advancing 0.29% or 0.11 points. Due to strong positive momentum, the stock ended at $38.15, which is also near the day’s high of $38.24. The stock began the session at $37.89 and the volume stood at 16,87,050 shares. The 52-week high of the shares is $51.88 and the 52 week low is $37.41. The company has a current market capitalization of $98,206 M and it has 2,57,42,11,400 shares in outstanding.

Sanofi SA (ADR)(SNY) last announced its earnings results on Jul 29, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $9.12B. Analysts had an estimated revenue of $10.19B. Earnings per share were $1.47. Analysts had estimated an EPS of $0.75.

Sanofi SA is a healthcare company focused on patient needs and engaged in the research development manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals Human Vaccines via Sanofi Pasteur and Animal Health via Merial. The Company invests in emerging markets diabetes solutions vaccines consumer health care animal health genzyme and other products. The emerging markets platform includes products from all three of the Company’s principal activities. Under the Company’s Pharmaceuticals business products are grouped into the key fields of diabetes solutions rare diseases multiple sclerosis oncology thrombosis and cardiovascular disease prevention nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *